Theralink Technologies Inc (THER)
Theralink Technologies Inc. is a common stock listing on OTC Markets tied to a healthcare company focused on biotechnology and precision medicine. The company describes itself as a commercial-stage molecular data-generating business that develops and commercializes oncology-related products in the United States. Its technology includes a patented phosphoprotein and protein biomarker platform and laboratory developed test technology aimed at oncology and drug development applications. Theralink also provides precision oncology data through its Reverse Phase Protein Array assays, which are intended to help biopharmaceutical companies and clinical oncologists identify likely responders and non-responders to FDA-approved and investigational therapies. The company was previously known as OncBioMune Pharmaceuticals, Inc. and adopted the Theralink Technologies name in September 2020. It is headquartered in Golden, Colorado.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-THER
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
6.151 K
|
